1-3 of 3
Gilca Nachtigal, MD
Close
Sort by
Journal Articles

Impact of Comorbidity In Event-Free Survival, Toxicity and Adherence to Treatment In Chronic Myeloid Leukemia Patients Treated with Imatinib

Laura Fogliatto, MD, Marcelo Capra, MD, Mariza Schaan, MD, Katia Fassina, MD, Mario Sérgio Fernandes, MD, Marco Antônio Schilling, MD, Denise Almeida, MD, Moema Nene, MD, Tânia Hellwig, MD, Gilca Nachtigal, MD, Adriana Zardo João, MD, Andréia Dias Almeida, MD, Tito Vanelli Costa, MD, Erica Lammerhirt Ottoni, MD, Christina G S Fraga, MD, Liane Esteves Daudt, MD, PhD, Lucia Silla, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 2296.
https://doi.org/10.1182/blood.V116.21.2296.2296
Published: 2010
Journal Articles

Important Role of Early Therapy and Maintaining Uninterrupted Treatment In the Outcomes of Chronic Myelogenous Leukemia Patients Treated with Imatinib

Erica Lammerhirt Ottoni, MD, Marcelo Capra, MD, Mariza Schaan, MD, Marco Antônio Schilling, MD, Katia Fassina, MD, Mario Sérgio Fernandes, MD, Denise Almeida, MD, Moema Nene, MD, Tânia Hellwig, MD, Tito Vanelli Costa, MD, Adriana Zardo, MD, Andréia Dias Almeida, MD, Gilca Nachtigal, MD, Christina G S Fraga, MD, Liane Esteves Daudt, MD, PhD, Lucia Silla, MD, PhD, Laura Fogliatto, MD
Journal: Blood
Blood (2010) 116 (21): 2300.
https://doi.org/10.1182/blood.V116.21.2300.2300
Published: 2010
Journal Articles

Results of Imatinib Therapy In Patients with Early and Late Chronic-Phase Chronic Myeloid Leukemia In a South Brazilian Cohort.

Marcelo Capra, MD, Mariza Shaan, MD, Katia Fassina, MD, Mario Sérgio Fernandes, MD, Marco Antônio Schilling, MD, Denise Almeida, MD, Moema Nene, MD, Tânia Hellwig, MD, Gilca Nachtigal, MD, Adriana Zardo, MD, Andréia Dias Almeida, MD, Tito Vanelli Costa, MD, Erica Lammerhirt Ottoni, MD, Mayde Seadi Torriani, Christina G S Fraga, MD, Liane Esteves Daudt, MD, PhD, Lucia Silla, MD, PhD, Laura Fogliatto, MD
Journal: Blood
Blood (2010) 116 (21): 4487.
https://doi.org/10.1182/blood.V116.21.4487.4487
Published: 2010